SCYNEXIS
SCYX
#10674
Rank
A$35.38 M
Marketcap
A$3.56
Share price
-9.02%
Change (1 day)
291.08%
Change (1 year)

SCYNEXIS (SCYX) - Net assets

Net assets on the balance sheet as of June 2026 : A$0.10 Billion

According to SCYNEXIS's latest financial reports the company has A$0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

SCYNEXIS - Net assets on balance sheet (from 2013 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$73.71 M-16.75%
2024-12-31$A$88.54 M-17.32%
2023-12-31$A$0.10 B2154.15%
2022-12-31$A$4.75 M-91.65%
2021-12-31$A$56.9 M92.28%
2020-12-31$A$29.59 M60.7%
2019-12-31$A$18.41 M-58.45%
2018-12-31$A$44.32 M61.62%
2017-12-31$A$27.42 M-43.23%
2016-12-31$A$48.3 M-16.11%
2015-12-31$A$57.58 M40.97%
2014-12-31$A$40.84 M-273.91%
2013-12-31$-A$23.49 Million26.29%
2012-12-31$-A$18.6 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Galmed Pharmaceuticals
GLMD
A$19.1 M-80.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
A$1.51 B 1,413.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
A$5.31 B 5,192.10%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
A$0.12 B 28.20%๐Ÿ‡บ๐Ÿ‡ธ USA